Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (1524)	5/14/2003 12:51:02 PM
From: Ian@SI	Read Replies (1) \| Respond to of 3044

I've picked up the impression that those symptoms were pre-existing in the pts treated; V certainly was no help for those symptoms in those pts. When pts without those symptoms were treated with V, they tended not to develop them. V will now be available to pts much earlier in the disease process (after only 2 failed treatments rather than 6). I have presumed that healthier pts with fewer existing symptoms would be in that pt population. In these circumstances, is it unrealistic to hope that side effects from V may be minimal rather than pronounced? No big deal. I was just wondering if you had side effect insights that I have missed. Ian